Royal Bank of Canada restated their outperform rating on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) in a report released on Wednesday morning,Benzinga reports. The firm currently has ...

Vanguard to pay $106.41M penalty for misleading investors on capital gains distributions and tax consequences in target date ...

Wall Street is suddenly uneasy about Trump's agenda, and the markets are sending him a message ...

Fintel reports that on January 16, 2025, UBS downgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN) from Buy ...

Drug maker Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies , a biopharmaceutical company, Bloomberg ...

Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by equities ...

Fintel reports that on January 10, 2025, B. Riley Securities initiated coverage of Eton Pharmaceuticals (NasdaqGM:ETON) with ...

If that trend continues, it's unlikely the consumer staples, energy, real estate, healthcare, or materials sectors will beat ...

Vanguard High Dividend Yield ETF is well-diversified, primarily investing in large-cap, dividend-growing stocks. See why VYM ...

Learn More The Vanguard Australian Shares Index ETF ... share price rose by 171.15% to finish the year at $1.41. The Telix Pharmaceuticals share price lifted 144.14% to close at $24.61 on 31 ...

The information technology sector has a weighting of 49.1% in the Vanguard ETF, whereas its weighting in the S&P 500 is just 31.3%. The top three stocks in the above table are the only ones in the ...

Data source: Vanguard. Chart by author. Portfolio weightings are accurate as of Nov. 30, 2024 and subject to change. The information technology sector has a weighting of 49.1% in the Vanguard ETF ...